{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:19:21Z","timestamp":1790716761506,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,5,18]],"date-time":"2011-05-18T00:00:00Z","timestamp":1305676800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1007\/s11899-011-0090-1","type":"journal-article","created":{"date-parts":[[2011,5,17]],"date-time":"2011-05-17T10:23:17Z","timestamp":1305627797000},"page":"157-163","source":"Crossref","is-referenced-by-count":51,"title":["Primary Mediastinal Large B-Cell Lymphoma, Classic Hodgkin Lymphoma Presenting in the Mediastinum, and Mediastinal Gray Zone Lymphoma: What is the Oncologist To Do?"],"prefix":"10.1007","volume":"6","author":[{"given":"Cliona","family":"Grant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieron","family":"Dunleavy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska C.","family":"Eberle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Pittaluga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wyndham H.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine S.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,18]]},"reference":[{"key":"90_CR1","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Campo E, Swerdlow SH, Harris NL, et al. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. Feb 7 2011 (Epub ahead of print). This review discusses new concepts introduced into the 2008 WHO classification, including the concept of mediastinal gray zone lymphomas.","DOI":"10.1182\/blood-2011-01-293050"},{"issue":"Suppl 5","key":"90_CR2","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1023\/A:1008466208072","volume":"9","author":"T Rudiger","year":"1998","unstructured":"Rudiger T, Jaffe ES, Delsol G, et al. Workshop report on Hodgkin\u2019s disease and related diseases (\u2018grey zone\u2019 lymphoma). Ann Oncol. 1998;9 Suppl 5:S31\u20138.","journal-title":"Ann Oncol"},{"key":"90_CR3","first-page":"297","volume":"9","author":"ES Jaffe","year":"1992","unstructured":"Jaffe ES, Zarate-Osorno A, Medeiros LJ. The interrelationship of Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphomas\u2013lessons learned from composite and sequential malignancies. Semin Diagn Pathol. 1992;9:297\u2013303.","journal-title":"Semin Diagn Pathol"},{"key":"90_CR4","doi-asserted-by":"crossref","unstructured":"\u2022 Kuppers R. The biology of Hodgkin\u2019s lymphoma. Nat Rev Cancer 2009;9:15\u201327. This article is an excellent review on the biology of Hodgkin\u2019s lymphoma.","DOI":"10.1038\/nrc2542"},{"key":"90_CR5","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1084\/jem.184.4.1495","volume":"184","author":"H Kanzler","year":"1996","unstructured":"Kanzler H, Kuppers R, Hansmann ML, Rajewsky K. Hodgkin and Reed-Sternberg cells in Hodgkin\u2019s disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med. 1996;184:1495\u2013505.","journal-title":"J Exp Med"},{"key":"90_CR6","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1182\/blood.V97.2.496","volume":"97","author":"H Stein","year":"2001","unstructured":"Stein H, Marafioti T, Foss HD, et al. Down-regulation of BOB.1\/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood. 2001;97:496\u2013501.","journal-title":"Blood"},{"key":"90_CR7","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/oxfordjournals.annonc.a058617","volume":"4","author":"JM Andrieu","year":"1993","unstructured":"Andrieu JM, Roithmann S, Tourani JM, et al. Hodgkin\u2019s disease during HIV1 infection: the French registry experience. French Registry of HIV-associated Tumors. Ann Oncol. 1993;4:635\u201341.","journal-title":"Ann Oncol"},{"key":"90_CR8","doi-asserted-by":"crossref","unstructured":"Levine AM. Hodgkin\u2019s disease in the setting of human immunodeficiency virus infection. J Natl Cancer Inst Monogr 1998:37\u201342.","DOI":"10.1093\/oxfordjournals.jncimonographs.a024171"},{"key":"90_CR9","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1097\/00000478-199612000-00012","volume":"20","author":"C Bellas","year":"1996","unstructured":"Bellas C, Santon A, Manzanal A, et al. Pathological, immunological, and molecular features of Hodgkin\u2019s disease associated with HIV infection. Comparison with ordinary Hodgkin\u2019s disease. Am J Surg Pathol. 1996;20:1520\u20134.","journal-title":"Am J Surg Pathol"},{"key":"90_CR10","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/00000478-199610000-00015","volume":"20","author":"OW Kamel","year":"1996","unstructured":"Kamel OW, Weiss LM, van de Rijn M, Colby TV, Kingma DW, Jaffe ES. Hodgkin\u2019s disease and lymphoproliferations resembling Hodgkin\u2019s disease in patients receiving long-term low-dose methotrexate therapy. Am J Surg Pathol. 1996;20:1279\u201387.","journal-title":"Am J Surg Pathol"},{"key":"90_CR11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00000478-200001000-00008","volume":"24","author":"S Kumar","year":"2000","unstructured":"Kumar S, Fend F, Quintanilla-Martinez L, et al. Epstein-Barr virus-positive primary gastrointestinal Hodgkin\u2019s disease: association with inflammatory bowel disease and immunosuppression. Am J Surg Pathol. 2000;24:66\u201373.","journal-title":"Am J Surg Pathol"},{"key":"90_CR12","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/01.pas.0000180856.74572.73","volume":"29","author":"A Traverse-Glehen","year":"2005","unstructured":"Traverse-Glehen A, Pittaluga S, Gaulard P, et al. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin\u2019s lymphoma and mediastinal large B-cell lymphoma. Am J Surg Pathol. 2005;29:1411\u201321.","journal-title":"Am J Surg Pathol"},{"key":"90_CR13","first-page":"701","volume":"139","author":"C Schmid","year":"1991","unstructured":"Schmid C, Pan L, Diss T, Isaacson PG. Expression of B-cell antigens by Hodgkin\u2019s and Reed-Sternberg cells. Am J Pathol. 1991;139:701\u20137.","journal-title":"Am J Pathol"},{"key":"90_CR14","first-page":"475","volume":"139","author":"LR Zukerberg","year":"1991","unstructured":"Zukerberg LR, Collins AB, Ferry JA, Harris NL. Coexpression of CD15 and CD20 by Reed-Sternberg cells in Hodgkin\u2019s disease. Am J Pathol. 1991;139:475\u201383.","journal-title":"Am J Pathol"},{"key":"90_CR15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/path.1485","volume":"202","author":"C Loddenkemper","year":"2004","unstructured":"Loddenkemper C, Anagnostopoulos I, Hummel M, et al. Differential Emu enhancer activity and expression of BOB.1\/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas. J Pathol. 2004;202:60\u20139.","journal-title":"J Pathol"},{"key":"90_CR16","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1182\/blood.V94.9.3108","volume":"94","author":"HD Foss","year":"1999","unstructured":"Foss HD, Reusch R, Demel G, et al. Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin\u2019s disease provides further evidence for its B-cell origin. Blood. 1999;94:3108\u201313.","journal-title":"Blood"},{"key":"90_CR17","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0002-9343(80)90294-6","volume":"68","author":"AK Lichtenstein","year":"1980","unstructured":"Lichtenstein AK, Levine A, Taylor CR, et al. Primary mediastinal lymphoma in adults. Am J Med. 1980;68:509\u201314.","journal-title":"Am J Med"},{"key":"90_CR18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/ajcp\/112.2.241","volume":"112","author":"JP Higgins","year":"1999","unstructured":"Higgins JP, Warnke RA. CD30 expression is common in mediastinal large B-cell lymphoma. Am J Clin Pathol. 1999;112:241\u20137.","journal-title":"Am J Clin Pathol"},{"key":"90_CR19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00705408","volume":"409","author":"P Moller","year":"1986","unstructured":"Moller P, Lammler B, Eberlein-Gonska M, et al. Primary mediastinal clear cell lymphoma of B-cell type. Virchows Arch A Pathol Anat Histopathol. 1986;409:79\u201392.","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"90_CR20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0046-8177(99)90273-3","volume":"30","author":"M Paulli","year":"1999","unstructured":"Paulli M, Strater J, Gianelli U, et al. Mediastinal B-cell lymphoma: a study of its histomorphologic spectrum based on 109 cases. Hum Pathol. 1999;30:178\u201387.","journal-title":"Hum Pathol"},{"issue":"Suppl 3","key":"90_CR21","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1080\/10428190310001623810","volume":"44","author":"SA Pileri","year":"2003","unstructured":"Pileri SA, Zinzani PL, Gaidano G, et al. Pathobiology of primary mediastinal B-cell lymphoma. Leuk Lymphoma. 2003;44 Suppl 3:S21\u20136.","journal-title":"Leuk Lymphoma"},{"key":"90_CR22","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1182\/blood.V69.4.1087.1087","volume":"69","author":"P Moller","year":"1987","unstructured":"Moller P, Moldenhauer G, Momburg F, et al. Mediastinal lymphoma of clear cell type is a tumor corresponding to terminal steps of B cell differentiation. Blood. 1987;69:1087\u201395.","journal-title":"Blood"},{"key":"90_CR23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0002-9440(10)63815-1","volume":"162","author":"SA Pileri","year":"2003","unstructured":"Pileri SA, Gaidano G, Zinzani PL, et al. Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins. Am J Pathol. 2003;162:243\u201353.","journal-title":"Am J Pathol"},{"key":"90_CR24","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2559.2004.01969.x","volume":"45","author":"M Calaminici","year":"2004","unstructured":"Calaminici M, Piper K, Lee AM, Norton AJ. CD23 expression in mediastinal large B-cell lymphomas. Histopathology. 2004;45:619\u201324.","journal-title":"Histopathology"},{"key":"90_CR25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/1066896909331994","volume":"18","author":"ME Salama","year":"2010","unstructured":"Salama ME. Rajan Mariappan M, Inamdar K, Tripp SR, Perkins SL. The value of CD23 expression as an additional marker in distinguishing mediastinal (thymic) large B-cell lymphoma from Hodgkin lymphoma. Int J Surg Pathol. 2010;18:121\u20138.","journal-title":"Int J Surg Pathol"},{"key":"90_CR26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2559.2005.02175.x","volume":"47","author":"JF Garcia","year":"2005","unstructured":"Garcia JF, Mollejo M, Fraga M, et al. Large B-cell lymphoma with Hodgkin\u2019s features. Histopathology. 2005;47:101\u201310.","journal-title":"Histopathology"},{"key":"90_CR27","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","volume":"198","author":"A Rosenwald","year":"2003","unstructured":"Rosenwald A, Wright G, Leroy K, et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med. 2003;198:851\u201362.","journal-title":"J Exp Med"},{"key":"90_CR28","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","volume":"102","author":"KJ Savage","year":"2003","unstructured":"Savage KJ, Monti S, Kutok JL, et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood. 2003;102:3871\u20139.","journal-title":"Blood"},{"key":"90_CR29","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/blood-2010-05-282780","volume":"116","author":"MR Green","year":"2010","unstructured":"Green MR, Monti S, Rodig SJ, et al. Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. Blood. 2010;116:3268\u201377.","journal-title":"Blood"},{"key":"90_CR30","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Oschlies I, Burkhardt B, Salaverria I, et al. Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children. Haematologica 2011;96:262\u20138. This is a recent clinical study of mediastinal lymphomas in children, and is a useful comparison with the adult experience.","DOI":"10.3324\/haematol.2010.030809"},{"key":"90_CR31","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1038\/sj.onc.1205629","volume":"21","author":"CB Hertel","year":"2002","unstructured":"Hertel CB, Zhou XG, Hamilton-Dutoit SJ, Junker S. Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin\/Reed-Sternberg cells of classical Hodgkin lymphoma. Oncogene. 2002;21:4908\u201320.","journal-title":"Oncogene"},{"key":"90_CR32","doi-asserted-by":"crossref","unstructured":"\u2022 Ehlers A, Oker E, Bentink S, Lenze D, Stein H, Hummel M. Histone acetylation and DNA demethylation of B cells result in a Hodgkin-like phenotype. Leukemia 2008;22:835\u201341. This study provides insight into mechanisms of inducing a Hodgkin\u2019s-like phenotype through gene methylation and gene silencing.","DOI":"10.1038\/leu.2008.12"},{"key":"90_CR33","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Eberle FC, Rodriguez-Canales J, Wei L, et al. Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin\u2019s lymphoma and primary mediastinal large B-cell lymphoma. Haematologica 2011;96:558\u201366. This is the first biological study of gray zone lymphomas. It provides insight into the plasticity of immunophenotype and morphology of these tumors, and their transitional appearance.","DOI":"10.3324\/haematol.2010.033167"},{"key":"90_CR34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00000478-200103000-00003","volume":"25","author":"D Cazals-Hatem","year":"2001","unstructured":"Cazals-Hatem D, Andre M, Mounier N, et al. Pathologic and clinical features of 77 Hodgkin\u2019s lymphoma patients treated in a lymphoma protocol (LNH87): a GELA study. Am J Surg Pathol. 2001;25:297\u2013306.","journal-title":"Am J Surg Pathol"},{"key":"90_CR35","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1200\/JCO.1997.15.11.3338","volume":"15","author":"DL Longo","year":"1997","unstructured":"Longo DL, Glatstein E, Duffey PL, et al. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin\u2019s disease. J Clin Oncol. 1997;15:3338\u201346.","journal-title":"J Clin Oncol"},{"key":"90_CR36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1200\/JCO.1991.9.2.227","volume":"9","author":"DL Longo","year":"1991","unstructured":"Longo DL, Russo A, Duffey PL, et al. Treatment of advanced-stage massive mediastinal Hodgkin\u2019s disease: the case for combined modality treatment. J Clin Oncol. 1991;9:227\u201335.","journal-title":"J Clin Oncol"},{"key":"90_CR37","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1182\/blood-2004-04-1311","volume":"104","author":"DJ Straus","year":"2004","unstructured":"Straus DJ, Portlock CS, Qin J, et al. Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease. Blood. 2004;104:3483\u20139.","journal-title":"Blood"},{"key":"90_CR38","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1200\/JCO.2005.09.085","volume":"23","author":"RM Meyer","year":"2005","unstructured":"Meyer RM, Gospodarowicz MK, Connors JM, et al. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin\u2019s lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group. J Clin Oncol. 2005;23:4634\u201342.","journal-title":"J Clin Oncol"},{"key":"90_CR39","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1182\/blood-2010-04-278796","volume":"117","author":"SM Castellino","year":"2011","unstructured":"Castellino SM, Geiger AM, Mertens AC, et al. Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood. 2011;117:1806\u201316.","journal-title":"Blood"},{"key":"90_CR40","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1056\/NEJMoa022473","volume":"348","author":"V Diehl","year":"2003","unstructured":"Diehl V, Franklin J, Pfreundschuh M, et al. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin\u2019s disease. N Engl J Med. 2003;348:2386\u201395.","journal-title":"N Engl J Med"},{"key":"90_CR41","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1182\/blood.V94.10.3289.422k32_3289_3293","volume":"94","author":"PL Zinzani","year":"1999","unstructured":"Zinzani PL, Martelli M, Magagnoli M, et al. Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67)Gallium scan in 50 patients. Blood. 1999;94:3289\u201393.","journal-title":"Blood"},{"key":"90_CR42","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/sj.bjc.6601460","volume":"90","author":"G Todeschini","year":"2004","unstructured":"Todeschini G, Secchi S, Morra E, et al. Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B\/VACOP-B. Br J Cancer. 2004;90:372\u20136.","journal-title":"Br J Cancer"},{"key":"90_CR43","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/annonc\/mdq418","volume":"22","author":"M Rieger","year":"2011","unstructured":"Rieger M, Osterborg A, Pettengell R, et al. Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study. Ann Oncol. 2011;22:664\u201370.","journal-title":"Ann Oncol"},{"key":"90_CR44","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1182\/blood.V99.8.2685","volume":"99","author":"WH Wilson","year":"2002","unstructured":"Wilson WH, Grossbard ML, Pittaluga S, et al. Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy. Blood. 2002;99:2685\u201393.","journal-title":"Blood"},{"key":"90_CR45","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/sonc.2002.30151","volume":"29","author":"WH Wilson","year":"2002","unstructured":"Wilson WH, Gutierrez M, O\u2019Connor P, et al. The role of rituximab and chemotherapy in aggressive B-cell lymphoma: a preliminary report of dose-adjusted EPOCH-R. Semin Oncol. 2002;29:41\u20137.","journal-title":"Semin Oncol"},{"key":"90_CR46","doi-asserted-by":"crossref","unstructured":"Dunleavy K, Pittaluga S, Tay K, et al. Comparative clinical and biological features of primary mediastinal B-cell lymphoma (PMBL) and mediastinal grey zone lymphoma (MGZL). ASH Annual Meeting Abstracts. 2009;114:106.","DOI":"10.1182\/blood.V114.22.106.106"},{"key":"90_CR47","unstructured":"Dunleavy K, Pittaluga S, Shovlin M. Untreated Primary Mediastinal B-cell (PMBL) and Mediastinal Grey Zone (MGZL) Lymphomas: Comparison of biological features and clinical outcome following DA-EPOCH-R without radiation [abstract]. Submitted, 11th International Conference on Malignant Lymphoma, Lugano; 2011."},{"key":"90_CR48","unstructured":"\u2022\u2022 Steidl C, Lee T, Shah SP, Farinha P, et al. Tumor-associated macrophages and survival in classic Hodgkin\u2019s lymphoma. N Engl J Med 2010;362:875\u201385. This study explores the importance of tumor microenvironment in classic Hodgkin\u2019s lymphoma and shows that tumor-associated macrophages are prognostically relevant."},{"issue":"7338","key":"90_CR49","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature09754","volume":"471","author":"C Steidl","year":"2011","unstructured":"Steidl C, Shah SP, Woolcock BW, et al. MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. Nature. 2011;471(7338):377\u201381.","journal-title":"Nature."}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-011-0090-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11899-011-0090-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-011-0090-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T05:14:53Z","timestamp":1592543693000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11899-011-0090-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,18]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["90"],"URL":"https:\/\/doi.org\/10.1007\/s11899-011-0090-1","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,18]]}}}